. Latest Posts. Jackie Fairley says: “Clearly we are surprised and extremely disappointed. Created with Sketch. Hey, "smart", I concur with your message. $-0. ASX - Day TradingAnyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. ASX - By Stock. Overview. It looks like SPL will need a BLOCKBUSTER ANNOUNCEMENT with $$$$$ attached plus a SATURN ROCKET up its clacker to take off. Created with Sketch. 49M. ASX - By Stock. Hey, "smart", I concur with your message. m. Forums. . 2:00 am Eastern Standard Time Australia. NEVER - there should be an official corruption enquiry considering the Gov Funding and R&D reimbursements recieved by SPL and what actually was achieved and why they haven't been succesful - there's US companies flogging Povidine Iodine nasal spray and throat sprays left right and centre. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. If SPL come out with more data and partners or a potential pathway to sales, great, i will change my view and the price will likely spike. ASX - Short Term Trading. ASX - Day Trading. Market . 56. Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. Fortescue Metals Group Ltd (Fortescue) is an Australia-based company engaged in iron ore. , page-2. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). 5¢. 3. . In March 2020 the SPL share price dropped to a low of 0. Last post JoeSalami. 2. ASX - Day Trading. Magnum Mining and Exploration Limited is an Australia-based company (ASX: MGU), which is engaged in mineral exploration and project development in Nevada, US. 50 or thereabouts. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . . Forums. See All Discussions. 15. All along, SPL have said that they may sell off this entire arm of the business, or in fact once the Dep oncology advances further, perhsps split SPL into different businesses on the asx or to be sold off as completely separate businesses. Click for more information. “If humans respond in a similar way, the benefits of treatment. 88. Eight (8) contributors to the HC SPL thread made price predictions (thank. 2:00 am Eastern Standard Time Australia. Last updated 15. but hey don't take my word for it, see for yourself in the official SPL ASX announcement dated 17th April 2023 You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. Extract taken from recent interview with CEO of Starpharma Does it surprise you that big pharma hasn't come in and swooped in and bought the business to. Starpharma are 4+ years from their CRL for Vivagel and we really are none the wiser of what is going on apart from a snippet in the AGM presentation stating 'we. 3¢. Discussion. I was astounded to see that you Jackie were rewarded with a$200,000 bonus during this time. Cristal therapeutics. Notification of cessation of securities - SPL. Target our investor community with our suite of Hotcopper Advertising opportunities. A sad state of affairs IMO. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. The main difference between shareholders and the board and their illustrious leader seems to be just in use of English language, small discrepancies like "well advanced" might me to you or I an agreement is pending, can be expected shortly, what it means to Jackie it would seem is she has undertaken a google search to see who might sell a product such as Viraleze in an particular country. Click for more information. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. NSX - By Stock. 75. Comments. 57% 13. 9¢. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Created with Sketch. 1. In summary, there appears to be a massive financial incentive ($7m per year) for SPL to keep turnover below $20m, until such time as sufficient progress has been made on all fronts for profitability to become a. That's how markets work sometimes. . 06B ! Add to my watchlist. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. 5 years Starpharma has not publicly released any information to the ASX about progress of the partnership. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. ASX - Day TradingCurrent SPL CEO setting a pretty high bar here, especially in light of the less than sparkling track record. ASX - By Stock. Some years ago SPL failed an FDA trial for the same product when Jackie was CEO. Charts. An expat Indonesian friend did have search for me but didn't find any promotion etc a little while ago. Share It's confusing isn't it So what we have in pre-clinical trials Dep Docetaxel has been used in combination with Gemcitabine Dep Cabazitaxel has been used in combination with GemcitabineReading the TGA decision to fine Starpharma re Viraleze in 2021, and the requirement that SPL apply for approval of Viraleze as Medicine not Medical Device which has been the approval category in many other jurisdictions, I understand from questions I asked at the November 2022 AGM that SPL paid the fine and were concerned that there. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Created with Sketch. 73. Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). 0. New Zealand Dollar. Created with Sketch. Provide some keywords to assist in categorisation of your abstract. ASX - Day TradingMelbourne, Australia; 6 May 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that VIRALEZE™ antiviral nasal spray is now available for purchase by consumers in Europe via Starpharma’s webstore. There have been so many market sensitive announcements made and then ZEROfollow up on these announcements. 0¢ Sentiment: Hold Disclosure: Held LikesSPL 7013 is already approved for use in the body (via a mucous membrane) and there would seem to be no issue as regards safety. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. 0000. Join the HotCopper ASX share market forum today for free. Share It would be silly to be tight on cash. You got to wonder after huge volumes going through last 4 days and the SP reaching new lows. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. 0¢ Sentiment: Buy. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on PANCONTINENTAL ENERGY NL. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial. And that is my opinion too but about SPL. Created with Sketch. Twenty years later it’s 84. Canadian Dollar. This will make for sad reading. Join the HotCopper ASX share market forum today for free. 5. Hi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. it's a mess with multiple Substantial Holders dumping like this all while HQ remain. Join the HotCopper ASX share market forum today for free. Hey, "smart", I concur with your message. Created with Sketch. Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. The only double standard I see is that if any employee in the real world repeatedly told their boss that a project would definitely be delivered, every year since 2018 and the project has still not been delivered in early 2023 then they would be ceremoniously SACKED. Just wondering if anyone else took the time to report Starpharma to the ASX as I did? Remember, NOTHING will ever change if CEOs and Directors of public. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. . I visited their offices in Melbourne near the Alfred a few times and thought they were on to some pretty neat tech. Hey, "smart", I concur with your message. ASX - Day Trading. 0000. Latest Posts. Target our investor community with our. 9¢. Is the board simply resting on their collective (pre spl) laurels?Just in case you missed it HEALTHCARE Starpharma (SPL) Strong results from first in man Phase 1 DEP Docetaxel trial validate SPL’s DEP platform Safety. 0¢. ASX - By Stock. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. A correctly formatted example follows: Title of my presentation for the conference. Taking Cols scenario for a sting like buyout if the buyout price is higher than the highest price the company has reached there is no avenue for complaint. Advertise on HotCopper. Imo HotCopper posters must have an. The recent announcement about Viraleze nasal. This is a charting thread for those interested in the movements of the SPL SP. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Market Cap $. All that seems to happen is that new verses are sometimes added. ROFL. 5¢ Sentiment: Hold Disclosure: HeldThat's so funny col69 Antibotter post had you scrambling to find the link where he got that information then you copy paste the link and infer you knew already, if you did know you would for sure have posted this morning, some posters knew you were not one of them imo, still should have been an announcement let's hope results once collated. 43M. HotCopper is Australia's largest free and independent stock market trading forum for ASX share prices & stock market discussions. Latest Posts. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. Market . Created with Sketch. 0 Created with. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 409118. While the chart is not good there is a glimmer hope maybe emerging. Antibotter despite you starting 23 separate Starpharma threads in 3 weeks you do not own this Hotcopper forum. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . DISCOVER THE BATTERY METALS REVOLUTION. I think that the more time that passes without profits, the less likely that there will ever be profits. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. 0. . 0¢. Last updated 15. Our magic little formula may just be the answer. leaves 13+ million shares that were sold by someone else (maybe FIL or AG ??). 616553. 0. . Interesting write-up. 375% 0. IMO they haven't . Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer. Feb 28 (Reuters) - Starpharma Holdings Ltd (SPL) : HY REVENUE FROM CONTINUING OPERATIONS DOWN 16% TO A$1. Energy. Share Interesting and positive early pre-clinical results. As Waldemar Januszczak said when looking at the portrait of Mr & Mrs Andrews by Gainsborough "THERE IS SOMETHING GOING ON here". Can you imagine. 8985. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. 5. We, as investors in this company deserve to knowmore. Last updated 15. Attached link highlights some of the complexities involved more broadly. In part it oversees accelerated research initiatives to develop responses to unmet needs. Created with Sketch. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. Working in a. Charts. 75802. The reason I loaded up in the year post the last agm was because we we falsely told that vivagel would would be launched in Q1. Starpharma (SPL) Shares in the nano-biotechnology group bucked the falls in the wider market on Monday after it announced a deal with a division of US pharmaceutical giant Ely Lilly to extend the application of its technologies in the animal health area. 0. Last updated 15. My portfolio has risen 95% since I sold SPL with conviction. Latest Posts. Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. Forums. Join the HotCopper ASX share market. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. Target our investor community with our suite of. . 0¢. ASX - Day TradingSo the share price of SPL rose up to a high of $2. SPL conducts a "trial" (use that word loosely) in of all places WA !! Yet our commercial hotshots cannot arrange a deal with a WA based company who appear highly capable and connected in getting distribution to sought after sectors like "Allied Health practitioners, the corporate sector and government". Unusual to make that announcement?. it certainly is a confidence booster to keep on topping upGood luck with whatever investments you may hold at the moment, and if you’re still in SPL, hopefully it will get a bit of a bounce soon. Share Interesting and positive early pre-clinical results. ASX - By Stock. . Advertise on HotCopper. ” This, sadly, is not true. Created with Sketch. Forums. Last edited by sarge17: 28/11/22. 59pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on MAGNIS ENERGY TECHNOLOGIES LTD. Created with Sketch. 00%. ASX - Day Trading. bc. Some have been mentioned on this thread previously. Your post is very vague in its relationship somehow with spl, but the intent of the constant negative narrative is obvious. Market . The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial Review About this app. 36. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Last updated 15. GLTAH but for me SPL is still a strong AVOID until a development of substance is announced. ASX - By Stock. VivaGel BV/Fleurstat was for many years touted as being a company maker in it’s own right. Latest Posts. ASX - By Stock. . Share Google Eddy Sunarto to read article about Starpharma stopping the next disease outbreak this is a great article about Viraleze the comments from CEO Jackie Fairley may suggest she is already aware of the results coming out of London imo. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. 0¢. The recent announcement about Viraleze nasal. In SPL's case there is clearly another. . Share It is now 2 years and 8 months since CEO Jackie Fairley bought any shares in her own company on-market. SPL's current SP is about 15 cents, after many years (some say 20 years) of unprofitability, during which time substantial salaries and performance bonuses appear to have been paid. 6¢. 3. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Latest Posts. Toll free: 1-877-388-4440 Email: CTBTaxQuestions@gov. I should declare that I am. Still waiting for you @antibotter to explain why it appears you tried to influence newbies and less experienced investors into thinking that something big was imminent based on a comment in the SPL newsletter. Change in substantial holding. 9¢. Market Cap $5. I am STILL inviting comment on SPL and their Zika proclamations, and how this is evidence of SPL’s long standing crumb throwing method. My last 350 posts take me back over two years and cover about twenty different stocks. 43pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. Actually I worked for a research firm that supplied SPL with online medical literature and patent research back in the early 2000s. Looking at the short term, SPL's SP is currently perched above a technical support line at 50 cents. Created with Sketch. Latest Posts | Join the HotCopper forum today for free, page-1. Last updated 15. . 16. More. In summary, my observations about SPL are: Marketing - persistent. 36. Maybe some positive news coming out of Starpharma CEO's busines trip to America over coming daysFor shareholder it is a task of getting a CEO who can make hard decisions based on what does happen but with shrinking internal candidates progress it triggered red flags for me a sif you were very confident and could show progress and efficacy new candidated would and could be funded / partnered so IMO odd to close down or delay. ca/pst. IMO the Starpharma HQ kool-aide would be tasting pretty bitter these days. Created with Sketch. 4¢. I no longer regard SPL as an investment-grade stock. Latest Posts. Can anybody load up the most recent Bell Potter Analysis on SPL? I am unable to source it thanks. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. Share WOW! Exactly 2 years after the start of this trial and still: NONE OF THE PATIENTS MET THE FORMAL CRITERIA OF A RESPONSE This is according to AstraZeneca’s own data, which is exactly the same disappointing result they announced in the last update last year at the ASHA congress in the USA in Dec 2022. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. ASX - By Stock. 0¢. 5¢. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. ASX - By Stock. ASX - By Stock Forum | Join the HotCopper forum today for free. Comments. ASX - General. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer model (BT474). Forums. Last updated 14. 138. HotCopper is Australia's largest free and independent stock market trading forum for. Name/company Polymer Drug, class/loading method Delivery system type/size Clinical stage/indication; CPC634. ASX - By Stock. . Created with Sketch. SPL always has tantalising carrots to dangle before the eyes of investors. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 26. 5¢. Created with Sketch. Surely the political restraints. Its time SPL got down and dirty and prepare their WAR plan in anticipation of the trial being successful. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - By Stock. Follow your favourite stocks, view charts, track gainers and losers and discuss topics including politics, commodities, cryptocurrency and managed funds. I'd think that SPL will be covering all the bases required for a crack at 505b2, but with the necessary data to pivot to a phase 3 trial if. 8¢. 13. Created with Sketch. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Views. Forums. ASX - By Stock. The AGM has come and gone What did we learn from this meeting according to our attendee's who post on HotCopper forum When it comes to. 0834. The recent announcement about Viraleze nasal spray going into production in Jan 2021, trying to hit the Euro markets in q1-q2 2021, caused a stir in the SP. 14. This sort of action happens fairly often with SPL then followed by a pull back. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. Created with Sketch. $1. SPL Price at posting: 44. , page-4. Latest Posts. Forums. Last updated 15. 12. ASX - By Stock. Remember that according to AZ’s own data, no patient had yet met the formal criteria of a response. Market . This of course is on the back of long-serving lap dog and CFO/Secretary Nigel Baade resigning around the same time that the ASX asked Starpharma questions regarding continuous disclosure obligations and also whether a SPL announcement was tantamount to ramping. ASX - By Stock. Think SPL has a valuation of 500mil…based on potential, or just promise. ZEUS RESOURCES LIMITED. Latest Posts. You should withdraw the statement. This product was expected to produce rivers of. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. ASX - Day TradingCreated with Sketch. Join the HotCopper ASX share market forum today for free. 0¢. Target our investor community with our. The ASX is trying to crack down on many companies. Meanwhile SPL seems to get into more schoolyard fights and then disagreements with Authority than company I have watched. . 76. ASX - By Stock. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. 1dB. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. . . 30. Created with Sketch. Along with SPL's seemingly better ADC compared to AZ's Enhertu, perhaps Pascal Soriot is wondering if he jumped into bed with the the wrong partner in Daiichi-Sankyo. .